AbstractThe δ-sarcoglycan (SG) gene is deleted in hamsters with hereditary cardiomyopathies. Immunological analyses of heart before, but not after, the progression of cardiomyopathy (CM) revealed that the BIO 14.6 strain, a model of hypertrophic CM, heterogeneously preserved α- and γ-SG with loss of β- and δ-SG. In contrast, the TO-2 strain, a model of dilated CM, did not show either SG. Furthermore, in vivo transfer of the full length δ-SG gene to TO-2 hearts expressed all four SGs. Thus, this age- and strain-dependent features suggest a more feasible setting for TO-2 than BIO 14.6 to verify both CM progression and the efficacy of gene therapy
Cardiomyopathy is a puzzling complication in addition to skeletal muscle pathology for patients with...
We have previously demonstrated that gene therapy can rescue the phenotype and extend lifespan in th...
We have previously demonstrated that gene therapy can rescue the phenotype and extend lifespan in th...
AbstractThe δ-sarcoglycan (SG) gene is deleted in hamsters with hereditary cardiomyopathies. Immunol...
Background—One of the most important problems in developing in vivo cardiac gene transfer has been l...
Background—The success of muscular dystrophy gene therapy requires widespread and stable gene delive...
Background—The success of muscular dystrophy gene therapy requires widespread and stable gene delive...
The BIO14.6 hamster provides a useful model of hereditary cardiomyopathies and muscular dystrophy. P...
The BIO14.6 hamster provides a useful model of hereditary cardiomyopathies and muscular dystrophy. P...
The BIO14.6 hamster is an excellent animal model for inherited cardiomyopathy, because of its lethal...
AbstractCardiomyopathic hamster is a representative animal model for autosomal recessive cardiomyopa...
ObjectiveIt has been postulated recently that changes in cytoskeletal and sarcolemmal proteins initi...
Background: The BIO14.6 hamster is an excellent animal model for inherited cardiomyopathy, because o...
Cardiomyopathy is a puzzling complication in addition to skeletal muscle pathology for patients with...
Background: The BIO14.6 hamster is an excellent animal model for inherited cardiomyopathy, because o...
Cardiomyopathy is a puzzling complication in addition to skeletal muscle pathology for patients with...
We have previously demonstrated that gene therapy can rescue the phenotype and extend lifespan in th...
We have previously demonstrated that gene therapy can rescue the phenotype and extend lifespan in th...
AbstractThe δ-sarcoglycan (SG) gene is deleted in hamsters with hereditary cardiomyopathies. Immunol...
Background—One of the most important problems in developing in vivo cardiac gene transfer has been l...
Background—The success of muscular dystrophy gene therapy requires widespread and stable gene delive...
Background—The success of muscular dystrophy gene therapy requires widespread and stable gene delive...
The BIO14.6 hamster provides a useful model of hereditary cardiomyopathies and muscular dystrophy. P...
The BIO14.6 hamster provides a useful model of hereditary cardiomyopathies and muscular dystrophy. P...
The BIO14.6 hamster is an excellent animal model for inherited cardiomyopathy, because of its lethal...
AbstractCardiomyopathic hamster is a representative animal model for autosomal recessive cardiomyopa...
ObjectiveIt has been postulated recently that changes in cytoskeletal and sarcolemmal proteins initi...
Background: The BIO14.6 hamster is an excellent animal model for inherited cardiomyopathy, because o...
Cardiomyopathy is a puzzling complication in addition to skeletal muscle pathology for patients with...
Background: The BIO14.6 hamster is an excellent animal model for inherited cardiomyopathy, because o...
Cardiomyopathy is a puzzling complication in addition to skeletal muscle pathology for patients with...
We have previously demonstrated that gene therapy can rescue the phenotype and extend lifespan in th...
We have previously demonstrated that gene therapy can rescue the phenotype and extend lifespan in th...